Evidence map›Paper›PMID 41330376›Full record

ArticleCell systems2026

High-throughput mapping of modular regulatory domains in human RNA-binding proteins.

Abby R Thurm, Yaara Finkel, Cecelia Andrews, Xiangmeng S Cai, Colette Benko, Lacramioara Bintu

Abstract read
In one paragraph

Article in Cell systems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Human Synthetic Biology and Programmable Gene Regulation Control.Annual review of genomics and human genetics · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Abby R ThurmBiophysics Graduate Program, Stanford University School of Medicine, Stanford, CA 94305, USA.
Yaara FinkelDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA.
Cecelia AndrewsDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Xiangmeng S CaiDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA; Basic Sciences and Engineering Initiative, Betty Irene Moore Children's Heart Center, Lucile Packard Children's Hospital, Stanford, CA, USA.
Colette BenkoDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Lacramioara BintuDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA. Electronic address: lbintu@stanford.edu.

Funding

Medical Scientist Training ProgramT32GM145402 · NIGMS · STANFORD UNIVERSITY · PI Katrin F. Chua · 2022 to 2026
$10.0M
High-throughput development and characterization of compact tools for transcriptional and chromatin perturbationsR01HG011866 · NHGRI · STANFORD UNIVERSITY · PI MICHAEL C BASSIK, Lacramioara Bintu · 2021 to 2026
$6.9M
Single-cell analysis and synthetic control of mammalian chromatin dynamics and gene regulationR35GM128947 · NIGMS · STANFORD UNIVERSITY · PI Lacramioara Bintu · 2018 to 2026
$3.1M
High-Throughput Measurements of RNA-Mediated Regulation of Gene Expression and OncogenesisF30CA287739 · NCI · STANFORD UNIVERSITY · PI Abby Thurm · 2024 to 2026
$136k
NCI NIH HHS F30 CA287739NHGRI NIH HHS R01 HG011866NIGMS NIH HHS R35 GM128947NIGMS NIH HHS T32 GM145402
6 · The paper itself

Abstract

RNA regulation is central to tuning gene expression and is controlled by thousands of RNA-binding proteins (RBPs). While many RBPs require their full sequence to function, some act through modular domains that recruit larger regulatory complexes. Mapping these RNA-regulatory effector domains is important for understanding RBP function and designing compact RNA regulators. We developed a high-throughput recruitment assay (HT-RNA-Recruit) to identify RNA-downregulatory effector domains within human RBPs. By recruiting over 30,000 protein tiles from 367 RBPs to a reporter mRNA, we discovered over 100 RNA-downregulatory effector domains in 86 RBPs. Certain domains-for instance, KRABs-suppress gene expression upon recruitment to both DNA and RNA. We engineered inducible synthetic RNA regulators based on NANOS that can downregulate endogenous RNAs or maintain reporter expression at defined intermediate levels, as predicted by mathematical modeling. This work serves as a resource for understanding RNA regulators and expands the repertoire of RNA control tools. A record of this paper's transparent peer review process is included in the supplemental information.

Indexed as

RNA-Binding ProteinsGene Expression RegulationHigh-Throughput Screening AssaysHumansRNARNA, MessengerRNARNA-Binding ProteinsRNA, Messengergene regulationhigh-throughput screeningmammalian synthetic biologyRNA-binding proteinsRNA degradation

Identifiers

PMID41330376
PMCPMC13436589

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.